They’re easy to mistake for other conditions.

As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...

Good Morning America weatherman Sam Champion is sharing a positive forecast about his health. “Thank you Dr. Stam Lerakis and Dr. Sharma and the WONDERFUL team of nurses at @mountsinaimedicalcenter ...

A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely ...

Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today highlighted the important scientific and educational ...

Amarin Corporation plc (NASDAQ: AMRN) ("Amarin"), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today highlighted the important scientific and educational ...

Have you ever wondered how a simple doctor’s visit can turn into a major surgery in minutes?

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.

A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ever before. Researchers identified two previously unknown proteins in the ...